P1 - Cytarabine

This tender, designated as P1, concerns the procurement of Cytarabine. Cytarabine is a chemotherapy medication used primarily in the treatment of certain types of leukemia and lymphoma. This procurement is likely for a healthcare provider, such as a hospital or clinic, requiring a supply of this specific pharmaceutical product. The tender will specify the required dosage forms, quantities, packaging, and delivery timelines. It may also include requirements related to storage, handling, and quality assurance of the medication. The contracting authority is seeking a reliable supplier for this essential cancer treatment drug. Further details regarding the exact specifications and conditions for the supply of Cytarabine will be provided in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Primary Healthcare, Hospitals and Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.